Value from Nordic health data \u2013 VALO – Sitra<\/strong><\/a> Markus Kalliola, Program Director, Coordinator of Joint Action Towards TEHDAS 2 and VALO projects<\/p>\n\n\n\n14.15 European Health Data Space – a stealth revolution. <\/strong>Richard Bergstr\u00f6m, Vice President European Affairs, IQVIA<\/p>\n\n\n\n14.40 TBC<\/strong><\/em><\/p>\n\n\n\n15.05- 15.35 Coffee, exhibition and networking.<\/strong><\/p>\n\n\n\nUse of RWD and AI towards value based decision making and healthcare<\/u><\/em><\/strong><\/p>\n\n\n\n15.35 The global value of Nordic data \u2013 selected use cases.<\/strong> Emilie Toresson Grip, Director, Head of RWE and Analytics, Quantify Research<\/p>\n\n\n\n15.55 Secure Processing Environment (SPE) – Your Gateway from Individual Level RWD to RWE. <\/strong>Erkki Soini. CEO, ESiOR Oy. Chairman on the Board, Kuopio Health<\/p>\n\n\n\n16.15 Nordic data landscape today and tomorrow<\/strong>, Riikka-Leena Leskel\u00e4, Research Director and Senior Partner at Nordic Healthcare Group<\/p>\n\n\n\n16.35 Use of RWD\/RWE in medicines development and regulatory decision making<\/strong>, Sini Eskola, PhD Candidate at University of Utrecht and WHO Centre for Pharmaceutical Policy and Regulation; Director, Regulatory Strategy, EFPIA<\/p>\n\n\n\n16.55 <\/strong>Using Federated Data Networks and Common Data Models for Health Technology Assessment.<\/strong> Ravinder Claire, Scientific Adviser \u2013 Science Policy and Research Programme, National Institute for Health and Care Excellence<\/p>\n\n\n\n17.20 Comparative effectiveness of first line pembrolizumab vs. chemotherapy in advanced non-small cell Lung-cancer after approval and reimbursement: A Norwegian Population-Based Cohort Study. <\/strong>Simon Boge Brant, PhD, NordicRWE<\/p>\n\n\n\n17.40 Thank you for the Day and walking to the City Hall<\/strong><\/p>\n\n\n\n18.00- 19.30 The Networking Reception<\/strong><\/p>\n\n\n\nDay 2<\/strong><\/p>\n\n\n\nChairs: Martta Ranta, Head of Medical Research, Abbvie and Juha Laine, Nordic HEOR Manager and RWD Advisor, Roche<\/p>\n\n\n\n
Use of RWD and AI towards value based decision making and healthcare<\/u><\/em><\/strong><\/p>\n\n\n\n9.00 Value based healthcare, <\/strong>Irene Eriksson, EMEA Partnership Lead, J&J <\/em><\/p>\n\n\n\n9.25 Building a Foundation for Evidence-Based Healthcare: The Impact of Real-Time Data in clinical decision making, Real-World Evidence Generation and on building Registries<\/strong>. Joakim S\u00f6derberg, Head of Business Development, BCB Medical<\/p>\n\n\n\n9.45 Use of natural language processing and machine learning to extract smoking status from patient texts in Finnish data lakes: lung cancer outcomes related to smoking as case example, <\/strong>Olivia H\u00f6ls\u00e4, Data Scientist, Medaffcon Oy<\/p>\n\n\n\n10.00 Why does the Nordics exceed in RWE \u2013 or could we do better?<\/strong><\/p>\n\n\n\nReal-time hospital-level clinical cost-effectiveness RWD production and reporting at HUS\/HUCH<\/strong>. Sami Pakarinen, Chief Medical Officer of Clinical Auditing (deputy) at HUS\/HUCH<\/p>\n\n\n\nEU Case: IHI Prominent, digital platform for precision medicine<\/strong>, Linus J\u00f6nsson, Professor, Karolinska Institute<\/p>\n\n\n\nFireside discussion <\/strong>with Sami Pakarinen and Linus J\u00f6nsson<\/em> moderated by <\/strong>Lisse-Lotte Hermansson, Country Director Medaffcon AB<\/p>\n\n\n\n10.40<\/strong> Networking break<\/p>\n\n\n\n11.00<\/strong> Real4Reg \u2013 Unlocking Real-World Data with AI, <\/strong>Anna-Maija Tolppanen, Professor, University of Easten Finland<\/p>\n\n\n\n11.25 The Power of Next-Gen Anonymization: Secure, Compliant, and Accessible Data, <\/strong>Tuomo Pentik\u00e4inen, CEO, VEIL.AI<\/p>\n\n\n\n11.45 HealthHub Finland EDIH – Auria Clinical Informatics – Agile Path for RWD Research. <\/strong>Arho Virkki, Chief Analytics Officer, Wellbeing Services County of South-West Finland (Varha)<\/p>\n\n\n\n12.05 Real World Evidence Reveal Unjustified Antibiotic Use for the treatment of acne, <\/strong>Johanna Vinblad, Manager HEOR, Market Access & Healthcare Consulting, PharmaLex (part of Cencora)<\/p>\n\n\n\n12.30-13.30 Lunch<\/u><\/em><\/strong><\/p>\n\n\n\nUse of RWD and AI in Drug discovery and development<\/u><\/em><\/strong><\/p>\n\n\n\n13.30 Transforming drug development in the future using Large Scale Data to find novel treatments for under-studied medical needs, <\/strong>William Hennah, Senior Scientist Genomics at Orion Pharma Oy<\/p>\n\n\n\n13.55 <\/strong>The power of combining Norwegian Healthdata and AI: A case example from Novartis and Akershus University Hospital, Novartis<\/strong><\/p>\n\n\n\n14.30 Transforming Clinical Trial Practices through Real-World Data<\/strong>. Tero Ylisaukko-oja, CEO, founder, MedEngine Oy<\/p>\n\n\n\n14.50 TBC<\/strong><\/p>\n\n\n\n15.15<\/strong> TBC<\/strong><\/p>\n\n\n\n15.25-15.30 Thank you for participating and funding, Mia Bengtstr\u00f6m<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"5th Nordic RWE and AI conference 5th Nordic RWE and AI conference, 28-29 January 2025, Helsinki is organized by University of Helsinki and \u00c5bo Akademi University. This conference is supported by NordicPOP, NordicPharmaTrain and European Federation for Pharmaceutical Industries and Associations Efpia. The Company sponsors listed in the Program have enabled us to organize the…<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":""},"categories":[],"tags":[94,96,92,88,90],"class_list":["post-1071","events","type-events","status-publish","hentry","tag-clinical-trials","tag-nordic-conference","tag-real-world-data","tag-real-world-evidence","tag-rwe"],"acf":[],"lang":"en","translations":{"en":1071},"taxonomy_info":{"post_tag":[{"value":94,"label":"clinical trials"},{"value":96,"label":"Nordic conference"},{"value":92,"label":"real world data"},{"value":88,"label":"real world evidence"},{"value":90,"label":"RWE"}]},"featured_image_src_large":false,"author_info":[],"comment_info":"","pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/events\/1071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/events"}],"about":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/types\/events"}],"wp:attachment":[{"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/media?parent=1071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/categories?post=1071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.abo.fi\/madness\/wp-json\/wp\/v2\/tags?post=1071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"\"](\"https:\/\/sites.abo.fi\/madness\/wp-content\/uploads\/sites\/16\/2024\/10\/HY_pharmacy_logo-1.png\")
<\/figure>\n<\/div>\n\n\n\n![\"\"](\"https:\/\/sites.abo.fi\/madness\/wp-content\/uploads\/sites\/16\/2024\/10\/AAU_logo.png\")
<\/figure>\n<\/div>\n<\/div>\n\n\n\n